Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Patient Experience Across Dental Implant Drilling Protocols

11 novembre 2026 aggiornato da: RAQUEL GONZÁLEZ MARTÍNEZ, Cardenal Herrera University

Comparative Analysis of Patient Experience Among Under-drilling and Conventional Drilling in Dental Implants: a Randomized Double-blinded Study.

The goal of this clinical trial is to learn whether the drilling technique used to prepare the implant site affects the experience and satisfaction of adult patients receiving dental implants. The main questions it aims to answer are:

  • Do patients treated with under-drilling report a different experience, satisfaction and postoperative discomfort than patients treated with conventional drilling?
  • How are implant insertion torque, implant stability and bone density related to the pain and experience reported by patients?

Researchers will compare under-drilling (the implant site is prepared with a slightly narrower final drill than usual) with conventional drilling (the standard drilling sequence for the implant diameter). Both are standard clinical techniques.

Participants will:

  • Be randomly assigned to one of the two techniques, without knowing which one they receive
  • Have their dental implant(s) placed at the CEU Cardenal Herrera University Dental Clinic
  • Complete a questionnaire about their experience before surgery and immediately after surgery
  • Record their experience every day during the first week after surgery
  • Complete a quality-of-life questionnaire (OHIP-14) one week after surgery

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Study design: Single-center, randomized, double-blind, parallel-group clinical trial with two arms (1:1 allocation). Although the ethics committee-approved protocol describes the study as a randomized double-blinded cohort observational study, participants are randomly allocated to one of two standard implant site preparation techniques; the study is therefore registered as interventional according to ClinicalTrials.gov definitions. No experimental products are used.

Randomization and blinding: A computer-generated random sequence, stratified by age and sex, will be prepared before the start of the study and kept concealed. The surgeon will be informed of the allocated technique only at the time of surgery. Participants and the statistician performing the data analysis will remain blinded to group allocation.

Surgical procedure: All procedures will be performed under local anesthesia (4% articaine with 1:100,000 epinephrine) using a crestal mucoperiosteal incision and saline irrigation. In both groups, the osteotomy starts with a lanceolate drill and a 2 mm pilot drill to the planned length. In the under-drilling group, the drilling sequence stops at the drill prior to the standard final drill for the implant diameter; in the conventional group, the manufacturer's standard sequence is completed. Nobel Biocare or 3i implants will be used. Insertion torque will be recorded with the surgical motor and implant stability (ISQ) will be measured after placement. Bone density will be classified according to Misch (D1-D4) using preoperative 3D imaging and intraoperative assessment.

Perioperative care (identical in both groups): 0.12% chlorhexidine mouthwash before and after surgery, antibiotic prophylaxis and postoperative antibiotic treatment (amoxicillin, or azithromycin in penicillin-allergic patients), dexketoprofen as anti-inflammatory, and paracetamol 1 g as rescue analgesic.

Data collection: Sociodemographic and anthropometric data (age, sex, education level, employment status, weight, height and medication use) will be recorded. Patient experience will be assessed with an 11-item visual analogue scale (0-100 mm) before surgery, immediately after surgery and daily during the first 7 postoperative days. Oral health-related quality of life will be assessed with the OHIP-14 at day 7.

Sample size: Based on an estimated standard deviation of 1.5 and a minimum clinically important difference of 1.17, with alpha = 0.05 and 80% power, 26 participants per group are required (52 in total). Allowing for losses, 62 participants will be enrolled.

Statistical analysis: Independent t-tests, Pearson's chi-square and Fisher's exact tests will be used, with a significance level of 5%.

Tipo di studio

Interventistico

Iscrizione (Stimato)

62

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Valencia
      • Alfara del Patriarca, Valencia, Spagna, 46115
        • Clínica Odontológica Universitaria, Universidad CEU Cardenal Herrera
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 18 years or older
  • Partially or completely edentulous patients requiring dental implant placement
  • Signed informed consent

Exclusion Criteria:

  • Use of psychotropic or pain-modulating medication
  • Systemic conditions affecting bone healing
  • Use of medication known to interfere with bone metabolism
  • Pregnancy or breastfeeding
  • Allergy or intolerance to implant materials (e.g., titanium, zirconia)
  • Severe bruxism or severe temporomandibular joint (TMJ) disorders
  • Inability to follow postoperative care protocols or maintain basic oral hygiene
  • Psychological or cognitive impairment that may interfere with understanding or following postoperative care instructions
  • Inability to attend follow-up visits
  • Previous implant failure

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Under-drilling (UD)

Participants receive dental implant(s) placed using the under-drilling technique.

Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's drilling sequence stopping at the drill prior to the standard final drill for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded.

Comparatore attivo: Conventional drilling (CO)

Participants receive dental implant(s) placed using the conventional drilling technique.

Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's complete standard drilling sequence for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Patient Experience and Satisfaction (Visual Analogue Scale)
Lasso di tempo: Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7

Patient experience with the treatment assessed with an 11-item visual analogue scale (VAS). Each item is scored on a 100 mm line (0 = low, 50 = moderate, 100 = extreme). Higher scores indicate greater intensity of the assessed experience.

Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Oral Health-Related Quality of Life (OHIP-14)
Lasso di tempo: 7 days after surgery

Oral Health Impact Profile-14 questionnaire, covering 7 dimensions (functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap) with 2 items each. Total score range 0-56; higher scores indicate worse oral health-related quality of life.

7 days after surgery
Implant Stability Quotient (ISQ)
Lasso di tempo: During surgery (day 0)

Primary implant stability measured by resonance frequency analysis immediately after implant placement (ISQ units, 1-100; higher values indicate greater stability).

During surgery (day 0)
Implant Survival
Lasso di tempo: 7 days after surgery

Presence of the implant in situ without mobility, pain or signs of infection requiring removal.

7 days after surgery
Implant Insertion Torque
Lasso di tempo: During surgery (day 0)

Insertion torque (Ncm) recorded by the surgical motor (OsseoSet 300) at implant placement.

During surgery (day 0)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Bone Density (Misch Classification)
Lasso di tempo: Preoperatively and during surgery (day 0)

Bone density at the implant site classified as D1-D4 according to Misch, assessed on preoperative 3D imaging and confirmed intraoperatively during drilling.

Preoperatively and during surgery (day 0)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: RAQUEL GONZÁLEZ-MARTÍNEZ, DDS, MSc, PhD, Cardenal Herrera University
  • Investigatore principale: ISIDORO CORTELL-BALLESTER, MD, DDS, MSc, PhD, Cardenal Herrera University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 novembre 2026

Completamento primario (Stimato)

1 luglio 2027

Completamento dello studio (Stimato)

1 luglio 2027

Date di iscrizione allo studio

Primo inviato

11 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

11 novembre 2026

Primo Inserito (Effettivo)

17 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared. In accordance with the protocol approved by the ethics committee and with the EU General Data Protection Regulation (GDPR) and Spanish Organic Law 3/2018, access to the data is restricted to the research team, and the data will be destroyed after publication of the results.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi